Literature DB >> 11003181

Cost of illness studies: what is good about them?

D P Rice1.   

Abstract

Mesh：

Year:  2000        PMID： 11003181      PMCID： PMC1730654          DOI： 10.1136/ip.6.3.177

Source DB:  PubMed          Journal:  Inj Prev        ISSN： 1353-8047            Impact factor:   2.399


× No keyword cloud information.
  73 in total

Review 1.  Cost-of-Illness Studies: An Updated Review of Current Methods.

Authors:  Eberechukwu Onukwugha; Jacquelyn McRae; Alex Kravetz; Stefan Varga; Rahul Khairnar; C Daniel Mullins
Journal:  Pharmacoeconomics       Date:  2016-01       Impact factor: 4.981

Review 2.  Cost of lung cancer: a methodological review.

Authors:  Laurent Molinier; Christophe Combescure; Cristos Chouaïd; Jean-Pierre Daurès; Bruno Housset; Didier Fabre; Alain Grand; Alain Vergnenègre
Journal:  Pharmacoeconomics       Date:  2006       Impact factor: 4.981

Review 3.  The economic burden of incident venous thromboembolism in the United States: A review of estimated attributable healthcare costs.

Authors:  Scott D Grosse; Richard E Nelson; Kwame A Nyarko; Lisa C Richardson; Gary E Raskob
Journal:  Thromb Res       Date:  2015-11-24       Impact factor: 3.944

4.  Quality of life, resource use, and costs related to hip fracture in Estonia.

Authors:  M Jürisson; H Pisarev; J Kanis; F Borgström; A Svedbom; R Kallikorm; M Lember; A Uusküla
Journal:  Osteoporos Int       Date:  2016-02-23       Impact factor: 4.507

5.  Cost-of-illness studies: a guide to critical evaluation.

Authors:  Allison Larg; John R Moss
Journal:  Pharmacoeconomics       Date:  2011-08       Impact factor: 4.981

6.  Publication of Cost-of-Illness Studies: Does Methodological Complexity Matter?

Authors:  T Joseph Mattingly; C Daniel Mullins; Eberechukwu Onukwugha
Journal:  Pharmacoeconomics       Date:  2016-10       Impact factor: 4.981

Review 7.  Assessing the annual economic burden of preventing and treating anogenital human papillomavirus-related disease in the US: analytic framework and review of the literature.

Authors:  Ralph P Insinga; Erik J Dasbach; Elamin H Elbasha
Journal:  Pharmacoeconomics       Date:  2005       Impact factor: 4.981

8.  Direct costs of ankylosing spondylitis and its determinants: an analysis among three European countries.

Authors:  A Boonen; D van der Heijde; R Landewé; F Guillemin; M Rutten-van Mölken; M Dougados; H Mielants; K de Vlam; H van der Tempel; S Boesen; A Spoorenberg; H Schouten; Sj van der Linden
Journal:  Ann Rheum Dis       Date:  2003-08       Impact factor: 19.103

9.  The cost of Type 1 diabetes mellitus in the United Kingdom: a review of cost-of-illness studies.

Authors:  Jen Kruger; Alan Brennan
Journal:  Eur J Health Econ       Date:  2012-10-18

Review 10.  Cost of falls in old age: a systematic review.

Authors:  S Heinrich; K Rapp; U Rissmann; C Becker; H-H König
Journal:  Osteoporos Int       Date:  2009-11-19       Impact factor: 4.507
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.